Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$134K Buy
13,622
+795
+6% +$6.58K 0.01% 370
2025
Q1
$93.3K Buy
+12,827
New +$112K ﹤0.01% 385
2024
Q2
Sell
-21,830
Closed -$254K 338
2024
Q1
$254K Sell
21,830
-2,533
-10% -$28K 0.02% 297
2023
Q4
$272K Buy
24,363
+4,742
+24% +$43.6K 0.02% 246
2023
Q3
$303K Sell
19,621
-1,983
-9% -$33.3K 0.02% 206
2023
Q2
$409K Buy
21,604
+3,464
+19% +$60.8K 0.03% 163
2023
Q1
$276K Buy
+18,140
New +$237K 0.02% 244

Other funds holding ETNB

E Fund Management's ETNB Position: Q2 2025 in Review

E Fund Management increased its 89bio (ETNB) stake by 6.2% in Q2 2025, buying an estimated $6.58K and bringing the position to 13,622 shares worth $134K. The position accounts for 0.01% of the portfolio, ranked #370.

E Fund Management first reported a position in ETNB in Q1 2023 and has held it in 7 quarters since. The position peaked at $409K in Q2 2023. 184 funds tracked by Wall St. Rank hold ETNB as of Q2 2025.

  • E Fund Management held 13,622 shares of 89bio worth $134K as of Q2 2025.
  • E Fund Management bought 795 89bio shares in Q2 2025, an estimated $6.58K.
  • 89bio made up 0.01% of E Fund Management's portfolio in Q2 2025, its #370 holding.
  • E Fund Management first reported a position in 89bio in Q1 2023 and has held it in 7 quarters since.
  • E Fund Management's 89bio position peaked at $409K in Q2 2023.
  • 184 funds tracked by Wall St. Rank held 89bio as of Q2 2025.

Based on E Fund Management's 13F filing for Q2 2025, filed 15 Aug 2025.